Therapeutic Targets for Hepatic Fibrosis Driven by Hypoxia-Mediated Hepatic Stellate Cell Activation
Wenteng Li, Tong Li, Jingwei Mao · 2026
Read Therapeutic Targets for Hepatic Fibrosis Driven by Hypoxia-Mediated Hepatic Stellate Cell Activation by Wenteng Li, Tong Li, Jingwei Mao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13511175.txt.
Description
Wenteng Li, Tong Li, and Jingwei Mao review how low oxygen drives liver scarring through a star-shaped liver cell, in 2026 work. Scarring builds when injury persists and these stellate cells switch on, laying down excess tissue matrix. Low oxygen steadies a set of sensor proteins that switch on growth and stiffening genes, while vessel lining cells in the liver change form early in the process.
Once active, stellate cells worsen vessel changes and deepen oxygen shortage, and their signals feed back to strengthen the same sensors. That loop keeps scarring moving toward cirrhosis and raises death risk from chronic liver disease. The review maps current treatments, then weighs drug targets along the oxygen pathway by how likely they are to reach patients. The authors aim to guide the search for anti-scarring drugs that break the loop.
Catalog record
| CREATOR | Wenteng Li, Tong Li, Jingwei Mao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70296 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |